Pharmacyte Biotech, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Pharmacyte Biotech, Inc. (PMCB) on June 6, 2022, reporting events occurring on June 1, 2022. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance.
Material Changes
The Board of Directors announced that the 2022 Annual Meeting of Stockholders will be held on August 25, 2022. This date is more than 30 days from the anniversary of the 2021 Annual Meeting.
Guidance, Outlook, and Corporate Actions
- Annual Meeting: Scheduled for August 25, 2022. Specific time and location will be disclosed in the definitive proxy statement.
- Stockholder Proposals: Proposals or director nominations must be delivered to the principal executive offices no later than June 24, 2022.
- Compliance: All proposals must comply with Nevada law, SEC regulations, and the Company's bylaws.
Key Facts for Investor Verification
- Verify the definitive proxy statement for the exact time and location of the August 25, 2022 Annual Meeting.
- Confirm the June 24, 2022 deadline for submitting stockholder proposals or director nominations.
- Review the Company's bylaws and Nevada corporate law for specific requirements regarding proposal content and director eligibility.